.. Fonction-Épuratrice-et-de-dégradation, 36 La production de bile, p.36

.. Epuration-vasculaire-de-la-bilirubine, 38 Notion de premier passage hépatique et détoxification, p.41

S. Mécanisme-physio-pathologique-du, 92 L'hypothèse du sous-remplissage artériel, p.92

S. Classification-des, 98 SHR de type 1, p.99

C. Fr, Disponible sur: http://www.inserm.fr/thematiques/physiopathologie-metabolisme-nutrition/dossiers-d-information, p.2012, 2016.

S. Scaglione, S. Kliethermes, G. Cao, D. Shoham, R. Durazo et al., The Epidemiology of Cirrhosis in the United States, Journal of Clinical Gastroenterology, vol.49, issue.8, pp.690-696, 2015.
DOI : 10.1097/MCG.0000000000000208

C. Schutz and J. Helwig, Clinical, pathological and experimental studies, Surg Gyn Obstet, 1932.

M. Epstein, The Hepatorenal Syndrome, Hospital Practice, vol.24, issue.4, 1994.
DOI : 10.1002/hep.1840070629

S. Foie-voies-biliaires, In: Les fondamentaux de la pathologie digestive [Internet] Disponible sur: http://www.snfge.org/sites, p.39, 2014.

F. Demuynck, R. Bouzerar, and T. Yzet, Evaluation des flux hépatiques: IRM 3T vs Echo-Doppler [Internet] Journées Françaises de Radiologie Disponible sur: http://pe.sfrnet.org/Data, pp.2498-2503, 2007.
DOI : 10.1016/s0221-0363(07)81736-7

A. Tsiaras, . Hepatic-portal, and . System, The Visual MD. 2014 [cité 10 sept 2016] Disponible sur: http://www

S. Piciucchi, D. Barone, S. Sanna, A. Dubini, L. Goodman et al., The azygos vein pathway: an overview from anatomical variations to pathological changes, Insights into Imaging, vol.12, issue.5, pp.619-647, 2014.
DOI : 10.1111/j.1540-8159.1989.tb01881.x

W. Minari and . Pourtant, Journées Françaises de Radiologie; 2013; Service d'imagerie médicale CHU FB Monastir Disponible sur: http://pe.sfrnet.org/Data/ModuleConsultationPoster/pdf/2013/1/0664a9e1-788b-45d0-bd10- 5f1e5409b42e.pdf 13. Illustrations. Fig. 532. Gray, Henry, Anatomy of the Human Body. [Internet]. [cité 24 sept 2016]. Disponible sur, 1918.

A. Muller, M. Shaikh, C. Micol, E. Guillot, and P. Valette, Localisation des tumeurs hépatiques assistée par ordinateur : Évaluation des performances d'une méthode semi automatique innovante, pp.4-4, 2013.

V. Pichard, Régénération hépatique en conditions normales et pathologiques: Analyse des lignages cellulaires et étude des effets sur la transduction lentivirale, Nantes, 2011.

. Infocancer, Cancers du foie (hépatocarcinome) [Internet]. www.arcagy.org/Infocancer, Disponible sur, p.2015, 2016.

X. Splanchnology, The Liver. Gray, Henry Anatomy of the Human Body, 1918.

. Radiationtherapy, Hepatobiliary cancers liver, gallbladder and bile duct [Internet]. radiationtherapy.tk, Disponible sur, 2016.

. Institut-de-biochimie-et-génétique-cellulaires-umr-5095, Les corps cétoniques [Internet], Disponible sur, 2010.

. Netgen, Protéinurie : rappel physiologique et applications pratiques, Disponible sur, 2016.

. Physiologie and . Internet, Ecole Nationale Vétérinaire de Toulouse Disponible sur: http://physiologie.envt.fr/spip

C. Zinsou, Métabolisme de l'azote et de l'ammoniac [Internet] Cours présenté à: Université des Antilles, 2005.

E. Jaspard, Catabolisme de la partie azotée des acides aminés : le cycle de l'urée [Internet]

P. Lapierre and F. Alvarez, Le foie : un organe du système immunitaire ? médecine/sciences, nov, vol.23, issue.11, pp.985-90, 2007.
DOI : 10.1051/medsci/20072311985

URL : http://www.medecinesciences.org/articles/medsci/pdf/2007/12/medsci20072311p985.pdf

D. Doherty, S. Norris, L. Madrigal-estebas, G. Mcentee, O. Traynor et al., The Human Liver Contains Multiple Populations of NK Cells, T Cells, and CD3+CD56+ Natural T Cells with Distinct Cytotoxic Activities and Th1, Th2, and Th0 Cytokine Secretion Patterns, J Immunol. 15 août, vol.163, issue.4, pp.2314-2335, 1999.

A. Lau and A. Thomson, Dendritic cells and immune regulation in the liver, Gut, vol.52, issue.2, pp.307-321, 2003.
DOI : 10.1136/gut.52.2.307

S. Le-foie-un-organe-extraordinaire|-www, Société gastro-intestinale | www.mauxdeventre.org, Disponible sur, 2016.

Z. Laron, Insulin-like growth factor 1 (IGF-1): a growth hormone, Molecular Pathology, vol.54, issue.5, pp.311-317, 2001.
DOI : 10.1136/mp.54.5.311

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187088/pdf

A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg, and T. Jørgensen, Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart Disease: A Population-Based Case-Control Study, Circulation, vol.106, issue.8, pp.939-983, 2002.
DOI : 10.1161/01.CIR.0000027563.44593.CC

R. Rao, C. Graffeo, R. Gulati, M. Jamal, S. Narayan et al., Interleukin 17???Producing ????T Cells Promote Hepatic Regeneration in Mice, Gastroenterology, vol.147, issue.2, pp.473-484, 2014.
DOI : 10.1053/j.gastro.2014.04.042

K. Lowes, B. Brennan, G. Yeoh, and J. Olynyk, Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity, The American Journal of Pathology, vol.154, issue.2, pp.537-578, 1999.
DOI : 10.1016/S0002-9440(10)65299-6

C. Li, Y. Wang, W. Dong, S. Xiang, H. Liang et al., Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo, Cancer Letters, vol.311, issue.1, pp.1-10, 2011.
DOI : 10.1016/j.canlet.2011.05.035

T. Roskams, Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, Oncogene, vol.25, issue.27, pp.3818-3840, 2006.
DOI : 10.1038/sj.onc.1209558

X. Xu, G. Yuan, J. Deng, Y. Wu, W. Ge et al., Hepatic oval cells activated by hepatocyte apoptosis in diethylnitrosamine-induced rat liver cirrhosis, Saudi Med J. mai, vol.31, issue.5, pp.490-494, 2010.

K. Lowes, B. Brennan, G. Yeoh, and J. Olynyk, Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity, The American Journal of Pathology, vol.154, issue.2, pp.537-578, 1999.
DOI : 10.1016/S0002-9440(10)65299-6

N. Fausto and J. Campbell, The role of hepatocytes and oval cells in liver regeneration and repopulation, Mechanisms of Development, vol.120, issue.1, pp.117-147, 2003.
DOI : 10.1016/S0925-4773(02)00338-6

G. Gordon, G. Butz, J. Grisham, and W. Coleman, Isolation, short-term culture, and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats1, Transplantation, vol.73, issue.8, pp.1236-1279, 2002.
DOI : 10.1097/00007890-200204270-00008

URL : http://pdfs.journals.lww.com/transplantjournal/2002/04270/Isolation,_short_term_culture,_and_transplantation.8.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1508319484280;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSMS9EqQf0kXLjlLn4kGwfi7tCupfAB7DKbVKxVgXde1s;hash|qyKxf/MDOejoMahA0FdDog==

G. Gordon, W. Coleman, and J. Grisham, Temporal Analysis of Hepatocyte Differentiation by Small Hepatocyte-Like Progenitor Cells during Liver Regeneration in Retrorsine-Exposed Rats, The American Journal of Pathology, vol.157, issue.3, pp.771-86, 2000.
DOI : 10.1016/S0002-9440(10)64591-9

C. Oberlin, C. Vacher, and J. Berthelot, Précis d'anatomie -11e édition : Anatomie des membres -Ostéologie du thorax et du bassin -Anatomie de la tête et du cou, Lavoisier. (Atlas Grégoire & Oberlin, vol.11

J. Guitard and D. Lefebvre, Laboratoire d'anatomie: Le Rein

A. Pharmacorama, Disponible sur, 2015.

A. Letaief and . Le, CEC Gériatrie; 2013 mars 14 [cité 29 oct 2016]; Faculté de Médecine de Monastir, Disponible sur

|. Cirrhose and . Snfge, org -Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive

R. Britton, Metal-induced hepatotoxicity. Semin Liver Dis, févr, vol.16, issue.1, pp.3-12, 1996.
DOI : 10.1055/s-2007-1007214

L. Maladie-de-wilson, Centre Hépato-Biliaire Paul Brousse, Disponible sur, 2014.

J. Teckman, Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Understanding and Future Therapy, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.278, issue.1, pp.35-43, 2013.
DOI : 10.1097/00005176-200407000-00007

L. Hépatites-auto-immunes, Centre Hépato-Biliaire Paul Brousse, Disponible sur, 2014.

B. Condat, A. Remy, V. Jouannaud, P. Lahmek, I. Rosa et al., Le recours aux soins pour cirrhose dans les services d'hépato-gastro-entérologie des centres hospitaliers généraux français, 2015.

A. Mokdad, A. Lopez, S. Shahraz, R. Lozano, A. Mokdad et al., Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis, BMC Medicine, vol.31, issue.1, p.145, 2014.
DOI : 10.1016/j.vaccine.2012.12.012

M. Lafortune, A. Denys, A. Sauvanet, and S. Schmidt, Anatomie du foie : ce qu'il faut savoir. Datarevues0221036300887-8-C21020 [Internet]. 19 mars, Disponible sur, p.122217, 2008.
DOI : 10.1016/s0221-0363(07)89916-1

C. Français and . Pathologistes, Cirrhose et complications [Internet] Université Médicale Virtuelle Francophone

A. M. Urgences-chez-le-cirrhotique, Société Francaise de Médecine d'Urgence; 2010. 283-295 p. (Troubles hydro-électrolytiques dans la cirrhose) Disponible sur

M. Idrissi, A. Babakhoya, and M. Hida, Apport de l'endoscopie digestive dans l'hypertension portale de l'enfant: à propos de 68 cas, Disponible sur, 2012.

I. Fantuzzi and F. Ascite, Etiologies, physiopathologie et traitement [Internet]. Cours DFGSM 2 présenté à; 2015 déc 15, 2016.

Y. Ozier and C. Lentschener, Anesthésie-réanimation de l'insuffisant hépatocellulaire, Éditions scientifiques et médicales Elsevier SAS, et Sfar. Conférences d'actualisation, pp.259-285, 2002.

I. Yigit, S. Hacievliyagil, Y. Seckin, R. Öner, and M. Kar?ncaoglu, The Relationship Between Severity of Liver Cirrhosis and Pulmonary Function Tests, Digestive Diseases and Sciences, vol.32, issue.4, pp.1951-1957, 2008.
DOI : 10.7326/0003-4819-122-7-199504010-00008

M. Dilly, F. Ettori, M. J. Samain, and E. , Anesthésie et réanimation en chirurgie hépatique et portale (y compris la transplantation hépatique), 2004.
DOI : 10.1016/j.emcar.2004.02.002

J. Cadranel, V. Jouannaud, and J. Duron, Prise en charge d???un hydrothorax h??patique, Revue des Maladies Respiratoires, vol.21, issue.3, pp.621-657, 2004.
DOI : 10.1016/S0761-8425(04)71372-8

N. Bezborodkina, A. Chestnova, S. Okovity, and B. Kudryavtsev, Activity of glycogen synthase and glycogen phosphorylase in normal and cirrhotic rat liver during glycogen synthesis from glucose or fructose, Experimental and Toxicologic Pathology, vol.66, issue.2-3
DOI : 10.1016/j.etp.2013.12.001

P. Houssel, R. Moreau, and L. Elkrief, Le diabète : un facteur à ne pas sous-estimer au cours de la cirrhose. Hépato-Gastro Oncol Dig, pp.254-62, 2012.

. Netgen, Encéphalopathie hépatique chez le patient atteint de cirrhose : nouveautés et recommandations pratiques [Internet] Revue Médicale Suisse. [cité 27 déc 2016]. Disponible sur: https://www.revmed, 2010.

N. Sipeki, P. Antal-szalmas, P. Lakatos, and M. Papp, Immune dysfunction in cirrhosis, World Journal of Gastroenterology, vol.20, issue.10, pp.2564-77, 2014.
DOI : 10.3748/wjg.v20.i10.2564

URL : http://doi.org/10.3748/wjg.v20.i10.2564

C. Bunchorntavakul, N. Chamroonkul, and D. Chavalitdhamrong, Bacterial infections in cirrhosis: A critical review and practical guidance, World Journal of Hepatology, vol.8, issue.6, pp.307-328, 2016.
DOI : 10.1016/j.ijid.2007.04.007

T. Poynard, G. Lassailly, E. Diaz, K. Clement, R. Caïazzo et al., Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data, PLoS ONE, vol.49, issue.3
DOI : 10.1371/journal.pone.0030325.s005

|. Insuffisance-hépato-cellulaire and . Snfge, org -Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive

P. Verpillat, S. Ares, and G. , Imagerie IRM de l'encéphalopathie hépatique aiguë, Congrès de Lille, 2011.

C. Scheau, R. Capsa, G. Popa, and I. Lupescu, Apport de l'IRM dans le diagnostic de l'encéphalopathie hépatique, 2013.

S. Buyse, C. Paugam-burtz, J. Stocco, and F. Durand, Adaptation des th??rapeutiques m??dicamenteuses en cas d???insuffisance h??patocellulaire, R??animation, vol.16, issue.7-8, pp.7-8576, 2007.
DOI : 10.1016/j.reaurg.2007.09.017

J. Mazoit, P. Sandouk, P. Zetlaoui, and J. Scherrmann, Pharmacokinetics of Unchanged Morphine in Normal and Cirrhotic Subjects, Anesthesia & Analgesia, vol.66, issue.4, pp.293-301, 1987.
DOI : 10.1213/00000539-198704000-00001

J. Lewis and J. Stine, Review article: prescribing medications in patients with cirrhosis - a practical guide, Alimentary Pharmacology & Therapeutics, vol.17, issue.Suppl. 2, pp.1132-56, 2013.
DOI : 10.3109/9781420021141-22

J. Benhamou, Traité d'hépatologie clinique. Éditions Flammarion. Médecine-Sciences, pp.134-64, 2002.

P. Miller, S. Book, and S. Stewart, Medical Treatment of Alcohol Dependence: A Systematic Review, The International Journal of Psychiatry in Medicine, vol.194, issue.1, pp.227-66, 2011.
DOI : 10.1007/s00213-007-0807-y

H. World, . Organization, . Guidelines, . For, C. Prevention et al., WHO Library Cataloguing-in-Publication Data, 2015.

H. Yang, J. Ryoo, and B. Yoo, Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection, International Journal of Clinical Pharmacy, vol.60, issue.1, pp.698-708, 2015.
DOI : 10.1002/hep.27151

H. Autorité and D. Santé, Consensus formalisé: prise en charge de l'hémochromatose liée au gène HFE (hémochromatose de type 1) [Internet]. HAS: service des recommandations professionnelles; Disponible sur

J. Duclos-vallée, P. Ichai, P. Chapuis, M. Misrhai, F. Woimant et al., Encyclopédie de l'Orphanet Disponible sur: https://www.orpha.net/data, 2006.

H. Autorité and D. Santé, Avis de la Commission de la Transparence: ALFALASTIN 33,33 mg/ml, poudre et solvant pour solution injectable. Flacon de poudre et flacon de solvant de 30 ml avec dispositif de transfert avec filtre avec aiguille, CIP : 566 118-9) [Internet]. Haute Autorité de Santé, 2005.

J. Duclos-vallée, Le traitement de l'hépatite autoimmune [Internet]. 5ème Journée d'Hépatologie du Centre Hépato-Biliaire; 2005 avr 6, Hopital Paul Brousse

|. Hypertension-portale and . Snfge, org -Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive

D. Gmbh, Transjugular intrahepatic portosystemic shunt [Internet]. DocCheck Pictures. [cité 1 avr 2017, Disponible sur

M. Rössle and A. Gerbes, TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update, Gut, vol.59, issue.7, pp.988-1000, 2010.
DOI : 10.1136/gut.2009.193227

A. Umgelter, W. Reindl, M. Miedaner, R. Schmid, and W. Huber, Failure of Current Antibiotic First-Line Regimens and Mortality in Hospitalized Patients with Spontaneous Bacterial Peritonitis, Infection, vol.23, issue.1, pp.2-8, 2009.
DOI : 10.1179/joc.1999.11.3.179

B. Runyon and J. Hoefs, Spontaneous vs secondary bacterial peritonitis. Differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy, Archives of Internal Medicine, vol.146, issue.8, pp.1563-1568, 1986.
DOI : 10.1001/archinte.146.8.1563

P. Berlioux and C. Bureau, Encéphalopathie hépatique. Form Médicale Contin En Hépato-Gastro-Entérologie, pp.1-7, 2014.

D. Wu, S. Wu, J. Lu, Y. Zhou, L. Xu et al., Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis, Gastroenterology Research and Practice, vol.18, issue.5, p.236963, 2013.
DOI : 10.1056/NEJMoa0907893

C. Traitement and . Hepatocellulaire, Centre Hépato-Biliaire Paul Brousse, Disponible sur, 2014.

F. Wong and L. Blendis, New challenge of hepatorenal syndrome: Prevention and treatment, Hepatology, vol.34, issue.6, pp.1242-51, 2001.
DOI : 10.1053/jhep.2001.29200

URL : http://onlinelibrary.wiley.com/doi/10.1053/jhep.2001.29200/pdf

V. Arroyo, M. Guevara, and P. Ginès, Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment, Gastroenterology, vol.122, issue.6, pp.1658-76, 2002.
DOI : 10.1053/gast.2002.33575

A. Cárdenas, P. Ginès, J. Uriz, X. Bessa, J. Salmerón et al., Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis, Hepatology, vol.34, issue.4, pp.671-677, 2001.
DOI : 10.1053/jhep.2001.27830

A. Ginès, A. Escorsell, P. Ginès, J. Saló, W. Jiménez et al., Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites, Gastroenterology, vol.105, issue.1, pp.229-265, 1993.
DOI : 10.1016/0016-5085(93)90031-7

V. Arroyo, P. Ginès, A. Gerbes, F. Dudley, P. Gentilini et al., Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis, Hepatology, vol.6, issue.suppl 3, pp.164-76, 1996.
DOI : 10.1002/hep.1840060216

O. Baraldi, C. Valentini, G. Donati, G. Comai, V. Cuna et al., Hepatorenal syndrome: Update on diagnosis and treatment, World J Nephrol. 6 nov, vol.4, issue.5, pp.511-531, 2015.

C. Ng, M. Chan, M. Tai, and C. Lam, Hepatorenal Syndrome, Clin Biochem Rev. févr, vol.28, issue.1, pp.11-18, 2007.

E. Yeung, E. Yong, and F. Wong, Renal Dysfunction in Cirrhosis: Diagnosis, Treatment, and Prevention

M. Medscape-gen, Disponible sur, 2004.

J. Llach, P. Ginès, V. Arroyo, A. Rimola, L. Titó et al., Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites, Gastroenterology, vol.94, issue.2, pp.482-489, 1988.
DOI : 10.1016/0016-5085(88)90441-6

E. Solà, C. Solé, and P. Ginès, Management of uninfected and infected ascites in cirrhosis, Liver International, vol.362, pp.109-124, 2016.
DOI : 10.1056/NEJMoa0907893

P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas et al., Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis, New England Journal of Medicine, vol.341, issue.6, pp.403-412, 1999.
DOI : 10.1056/NEJM199908053410603

S. Taneja and R. Dhiman, Prevention and Management of Bacterial Infections in Cirrhosis, International Journal of Hepatology, vol.118, issue.1, 3168849.
DOI : 10.1056/NEJMoa061115

J. Fernández, R. Del-arbol, L. Gómez, C. Durandez, R. Serradilla et al., Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage, Gastroenterology, vol.131, issue.4, pp.1049-1056, 2006.
DOI : 10.1053/j.gastro.2006.07.010

G. Testino, S. Leone, C. Ferro, and P. Borro, Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt, J Med Life. 12 juin, vol.5, issue.2, pp.203-208, 2012.

P. Mathurin, M. Abdelnour, M. Ramond, N. Carbonell, L. Fartoux et al., Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone, Hepatology, vol.32, issue.6, pp.1363-1372, 2003.
DOI : 10.1016/j.hep.2003.09.038

J. Casanova and R. Bataller, Alcoholic hepatitis: Prognosis and treatment, Gastroenterolog??a y Hepatolog??a, vol.37, issue.4, pp.262-270
DOI : 10.1016/j.gastrohep.2014.02.001

S. Kendrick, E. Henderson, J. Palmer, D. Jones, and C. Day, Theophylline improves steroid sensitivity in acute alcoholic hepatitis, Hepatology, vol.48, issue.1, pp.126-157, 2010.
DOI : 10.1016/j.jhep.2007.10.010

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.23666/pdf

E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds et al., Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial, Gastroenterology, vol.119, issue.6, pp.1637-1685, 2000.
DOI : 10.1053/gast.2000.20189

M. Thursz, P. Richardson, M. Allison, A. Austin, M. Bowers et al., Prednisolone or Pentoxifylline for Alcoholic Hepatitis, New England Journal of Medicine, vol.372, issue.17, pp.1619-1647, 2015.
DOI : 10.1056/NEJMoa1412278

URL : http://spiral.imperial.ac.uk/bitstream/10044/1/25846/2/nejmoa1412278.pdf

F. Keller, H. Heinze, F. Jochimsen, J. Passfall, D. Schuppan et al., Risk Factors and Outcome of 107 Patients with Decompensated Liver Disease and Acute Renal Failure (Including 26 Patients with Hepatorenal Syndrome): The Role of Hemodialysis, Renal Failure, vol.4, issue.2, pp.135-461819, 1995.
DOI : 10.1093/qjmed/86.10.649

P. Angeli, R. Volpin, G. Gerunda, R. Craighero, P. Roner et al., Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide, Hepatology, vol.333, issue.6, pp.1690-1697, 1999.
DOI : 10.1002/hep.510290629

M. Pizcueta, J. García-pagán, M. Fernández, R. Casamitjana, J. Bosch et al., Glucagon hinders the effects of somatostatin on portal hypertension, Gastroenterology, vol.101, issue.6, pp.1710-1715, 1991.
DOI : 10.1016/0016-5085(91)90411-D

C. Sieber, F. Lee, and R. Groszmann, Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats, Hepatology, vol.23, issue.5, pp.1218-1241, 1996.
DOI : 10.1002/hep.510230541

K. Werling and N. Chalasani, What is the Role of Midodrine in Patients with Decompensated Cirrhosis?, Gastroenterol Hepatol. févr, vol.7, issue.2, pp.134-140, 2011.

P. Angeli, R. Volpin, D. Piovan, A. Bortoluzzi, R. Craighero et al., Acute effects of the oral administration of midodrine, an ?-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites, Hepatology, vol.26, issue.4, pp.937-980, 1998.
DOI : 10.1002/hep.510280407

C. Duvoux, D. Zanditenas, C. Hézode, A. Chauvat, J. Monin et al., Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study, Hepatology, vol.105, issue.2, pp.374-80, 2002.
DOI : 10.1053/jhep.2002.34343

A. Junior, A. Farias, A. Lac-d-', F. Carrilho, and L. Malbouisson, Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis, PLoS ONE, vol.134, issue.9, p.107466, 2014.
DOI : 10.1371/journal.pone.0107466.s001

P. Beaulieu and C. Lambert, Précis de pharmacologie : du fondamental à la clinique. Montréal: Les presses de l, 2010.

D. Kock, M. Laterre, P. Andruetto, P. Vanderessen, L. Dekrom et al., Ornipressin (Por 8): An Efficient Alternative to Counteract Hypotension During Combined General/Epidural Anesthesia, Anesthesia & Analgesia, vol.90, issue.6, pp.1301-1308, 2000.
DOI : 10.1097/00000539-200006000-00008

V. Gülberg, M. Bilzer, and A. Gerbes, Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine, Hepatology, vol.28, issue.Suppl, pp.870-875, 1999.
DOI : 10.1002/hep.510280219

H. Rajekar and Y. Chawla, Terlipressin in hepatorenal syndrome: Evidence for present indications, Journal of Gastroenterology and Hepatology, vol.29, pp.109-123, 2011.
DOI : 10.1053/jhep.2002.35819

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2010.06583.x/pdf

E. Hackenthal, M. Paul, D. Ganten, and R. Taugner, Morphology, physiology, and molecular biology of renin secretion, Physiol Rev. 1 oct, vol.70, issue.4, pp.1067-116, 1990.

P. Manning, D. Schwartz, N. Katsube, S. Holmberg, and P. Needleman, Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis, Science, vol.229, issue.4711, pp.395-402, 1985.
DOI : 10.1126/science.2990050

S. Sagi, S. Mittal, K. Kasturi, and G. Sood, Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials, Journal of Gastroenterology and Hepatology, vol.36, issue.4 Pt 1, pp.880-885, 2010.
DOI : 10.1053/jhep.2002.35819

K. Lenz, R. Buder, L. Kapun, and M. Voglmayr, Treatment and management of ascites and hepatorenal syndrome: an update, Therapeutic Advances in Gastroenterology, vol.40, issue.4, pp.83-100, 2015.
DOI : 10.1002/hep.20262

URL : http://journals.sagepub.com/doi/pdf/10.1177/1756283X14564673

G. Decaux, A. Soupart, and G. Vassart, Non-peptide arginine-vasopressin antagonists: the vaptans, The Lancet, vol.371, issue.9624, pp.1624-1656, 2008.
DOI : 10.1016/S0140-6736(08)60695-9

F. Aubrun and S. Duperret, Hépatologie aiguë en anesthésie, réanimation, urgence. Arnette; 2013

F. Wong, L. Pantea, and K. Sniderman, Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome, Hepatology, vol.40, issue.1, pp.55-64, 2004.
DOI : 10.1136/gut.40.5.664

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.20262/pdf

B. Erly, W. Carey, B. Kapoor, J. Mckinney, M. Tam et al., Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options, Seminars in Interventional Radiology, vol.32, issue.04, pp.445-54, 2015.
DOI : 10.1055/s-0035-1564794

P. Jepsen, H. Vilstrup, P. Andersen, T. Lash, and H. Sørensen, Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study, Hepatology, vol.38, issue.1, pp.214-234, 2008.
DOI : 10.1136/bmj.311.6999.222

S. Iwatsuki, M. Popovtzer, J. Corman, M. Ishikawa, C. Putnam et al., Recovery from Hepatorenal Syndrome after Orthotopic Liver Transplantation, New England Journal of Medicine, vol.289, issue.22, pp.1155-1164, 1973.
DOI : 10.1056/NEJM197311292892201

B. Demirbas, T. Piskin, M. Dayangac, O. Yaprak, L. Oklu et al., Successful treatment of severe hepatorenal syndrome with living donor liver transplantation, Hepatogastroenterology. oct, vol.59, issue.119, pp.2305-2311, 2012.

T. Restuccia, R. Ortega, M. Guevara, P. Ginès, C. Alessandria et al., Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study, Journal of Hepatology, vol.40, issue.1, pp.140-146, 2004.
DOI : 10.1016/j.jhep.2003.09.019

B. Runyon, . Aasld-practice-guidelines, and . Committee, Management of adult patients with ascites due to cirrhosis: An update, Hepatology, vol.101, issue.6, pp.2087-107, 2009.
DOI : 10.1016/0016-5085(91)90403-8

L. Gex, C. Bernard, and L. Spahr, Scores en hépatologie : Child-Pugh, MELD et Maddrey Rev Médicale Suisse Disponible sur: https://www.revmed.ch/RMS, 2010.

R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim et al., Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, vol.124, issue.1, pp.91-97, 2003.
DOI : 10.1053/gast.2003.50016

G. Potdevin, M. Sinegre, V. Bouton, and P. Marcellin, Cas clinique d'hépatite C, J Pharm Clin. 1 janv, vol.25, issue.1, pp.67-71, 2006.

É. Pouyet-poulet, M. Sauvant, D. Pépin, and R. Planche, Le pharmacien d'officine face au problème des buveurs excessifs, Summary, pp.237-285, 2008.
DOI : 10.3917/spub.013.0237

L. Connor and G. Teehan, A Case of Type I Hepatorenal Syndrome Treated with Vasopressin, Open Journal of Nephrology, vol.03, issue.03, p.135, 2013.
DOI : 10.4236/ojneph.2013.33025

K. Sutariya, V. Tank, A. Modi, and P. , Combined Liver-Kidney Transplantation for Hepatorenal Syndrome, Int J Organ Transplant Med, vol.6, issue.3, pp.131-134, 2015.